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The human La autoantigen has been shown to interact
with the internal ribosome entry site (IRES) of hepatitis
C virus (HCV) in vitro. Using a yeast three-hybrid sys-
tem, we demonstrated that, in addition to full-length La
protein, both N- and C-terminal halves were able to in-
teract with HCV IRES in vivo. The exogenous addition of
purified full-length and truncated La proteins in rabbit
reticulocyte lysate showed dose-dependent stimulation
of HCV IRES-mediated translation. However, an addi-
tive effect was achieved adding the terminal halves to-
gether in the reaction, suggesting that both might play
critical roles in achieving full stimulatory activity of the
full-length La protein. Using computational analysis,
three-dimensional structures of the RNA recognition
motifs (RRM) of the La protein were independently mod-
eled. Of the three putative RRMs, RRM2 was predicted
to have a good binding pocket for the interaction with
the HCV IRES around the GCAC motif near the initiator
AUG and RRM3 binds perhaps in a different location.
This observation was further investigated by the filter-
binding and toe-printing assays. The results presented
here strongly suggest that both the N- and C-terminal
halves can interact independently with the HCV IRES
and are involved in stimulating internal initiation of
translation.
Hepatitis C virus (HCV)1 is a single-stranded, positive-sense
enveloped RNA virus classified in a separate genus of the
family Flaviviridae (1). HCV has been shown to be the primary
causative agent of non-A, non-B viral hepatitis, which often
leads to development of chronic hepatitis, cirrhosis, or hepato-
cellular carcinoma (2, 3). The HCV genome RNA is 9.5 kb in
length and consists of a 5-untranslated region (UTR), a long
open reading frame encoding the viral polyprotein, and a 3-
UTR (4). The translation initiation of HCV occurs by cap-
independent mechanism that is directed by the highly struc-
tured 5-UTR (341 nt long), consisting of four stem-loops and a
pseudoknot structure. The 5-UTR contains unique cis-acting
element called “internal ribosome entry site” (IRES) that me-
diates 5-cap-independent internal initiation of translation (5–
9). The HCV IRES element requires most of the 5-UTR, except
the first 40 nt, and extends to a short stretch (30–40 nt) of
sequence downstream of the initiator AUG codon (6, 10). Hep-
atitis C virus IRES is significantly different from that of picor-
naviruses (e.g. poliovirus) with respect to length, secondary and
tertiary structure of the 5-UTR RNA (11). Also in contrast to
picornavirus IRES, HCV IRES does not have a strict require-
ment for the canonical initiation factors (eIFs) other than eIF2
and eIF3 (12). A number of cellular polypeptides have been
shown to specifically interact with the HCV 5-UTR RNA,
which include polypyrimidine-tract binding protein (p57/60)
(13), human La antigen (La, p50/52) (14), poly(rC)-binding pro-
tein 2 (15), heterogeneous nuclear ribonucleoprotein L (p68)
(16), and ribosomal protein factors S9 and S5 (12). Interaction
of these proteins with the 5-UTR may be important for trans-
lation and/or replication of the HCV genome, although the
precise roles are not known yet.
The La protein (also called SS-B) was originally identified as
an autoantigen that was recognized by sera from patients with
systemic lupus erythematosus and Sjogren’s syndrome (17).
Homologues of La protein have been identified in fruit fly,
(Drosophila melanogaster) and in yeast (Saccharomyces cerevi-
siae) (18). Human La antigen is an RNA-binding protein, be-
longing to the RNA recognition motif (RRM) super family. It is
a 50/52-kDa protein, which is predominantly localized within
the nucleus and which functions in the maturation of RNA
polymerase III transcripts and the unwinding of double-
stranded RNA (19–22). La protein has been shown to be asso-
ciated with U1RNA (23), telomerase RNA (24), adenovirus VA
RNA (25), vesicular stomatitis virus leader RNA (26), influenza
virus (27), Sindbis virus (28), and the HIV TAR element (29).
The other targets of the La protein binding include the 5-UTRs
of poliovirus (30), hepatitis C virus (14), encephalomyocarditis
virus (31), and Bip mRNA (32). Interestingly, it has been shown
that La protein specifically interacts with both the 5- and
3-UTR of hepatitis C virus RNA (33). La protein plays a
functional role in internal initiation of translation where addi-
tion of purified La to RRL in the in vitro translation assays
using either HCV or poliovirus IRES resulted in stimulation of
the translation activity (14, 30). Sequestration of La in RRL
inhibits HCV IRES-mediated translation, which can be rescued
by exogenous addition of purified La protein. Different ap-
proaches of La depletion were employed to demonstrate the
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functional requirement of La protein on HCV IRES-mediated
translation. A small RNA called I-RNA (60 nt) originally iso-
lated from S. cerevisiae has been shown to bind to La protein
and inhibit HCV IRES-mediated translation (34). Similarly, a
SELEX RNA generated against La protein has been used to
compete with HCV 5-UTR for the La protein binding to block
the IRES-mediated translation (35). However, it has been
noted that HCV IRES has a lower requirement of La protein,
compared with poliovirus IRES (36). Similarly, in absence of La
protein, X-linked inhibitor of apoptosis protein IRES-mediated
translation is shown to be severely affected (37) and Bip IRES
activity is enhanced severalfold in presence of La protein (32).
Interestingly, binding of La protein to the HIV TAR sequence
alleviates the translational repression exerted by the TAR se-
quence on a downstream reporter gene (38) and, in the case of
encephalomyocarditis virus, La protein alleviates inhibitory
activity of surplus polypyrimidine tract-binding protein (31).
La protein has been shown to have three putative RRMs and
a basic region followed by a stretch of acidic region at the C
terminus (39). A truncated La protein (1–194), which still con-
tained RRM and bound the poliovirus 5-UTR, failed to stimu-
late poliovirus translation or correct the aberrant translation
in RRL (40), suggesting that binding of the La protein with the
RNA is insufficient to explain the activity. The C terminus also
contains a homodimerization domain; deletion of this domain
has been shown to abrogate the ability of La protein to enhance
IRES-mediated translation of poliovirus (41).
In this report we have demonstrated that both N- and C-
terminal halves of La protein are able to interact with HCV
IRES in vivo by the yeast three-hybrid assay system. The
relative binding affinities have been determined using filter-
binding assays. Furthermore, the biological relevance of these
interactions was studied by exogenous addition of purified full-
length and truncated La proteins in the in vitro translation
system using bicistronic constructs in rabbit reticulocyte ly-
sate. Interestingly, both the N- and C-terminal halves of La
proteins were able to stimulate the HCV IRES-mediated trans-
lation unlike the case in poliovirus IRES, suggesting that the
deletion of the C terminus does not abrogate the ability of La
protein to enhance the translation of hepatitis C virus. To date,
no crystallographic or NMR structure information is available
for either the full-length or individual domains of La protein.
Using computational analysis, we have searched for traditional
RRMs in the La protein. We have generated the three-dimen-
sional model of the RRM regions of the La protein by compar-
ative modeling on the basis of the closest homologues of known
structures determined using NMR or crystallography. The pre-
dicted secondary structure of the region 105–208 residues of La
(referred to as RRM2) showed similarity with that of RRM-
containing proteins of known structures. Additionally, using
comparative sequence and structural analysis, it is suggested
that the RRM2 within the N-terminal domain of La protein
binds HCV RNA at the GCAC motif near the initiator AUG.
The prediction was further investigated by the filter-binding
and toe-printing assays, which clearly demonstrated much
higher RNA binding affinity of the RRM2 at this region. The
results constitute the first report to demonstrate physical in-
teraction of La protein with the viral RNA in vivo and provide
direct evidence of the in vitro interactions of RRM2 of La
protein with the HCV IRES around the region encompassing
the initiator AUG and the GCAC motif.
EXPERIMENTAL PROCEDURES
Plasmids—HCV 1b encoding plasmid, pCV, was generously given by
Dr. Akio Nomoto and Dr. Tsukiyama-Kohara (University of Tokyo,
Tokyo, Japan). HCV 5-UTR along with 42-nt (18–383 nt) coding se-
quence was PCR-amplified from plasmid pCV and cloned between
HindIII and EcoRI sites of the mammalian expression vector pcDNA3
(Invitrogen) to generate pcDHCV-383. Similarly nt 1–341 of the HCV
5-UTR were PCR amplified from the clone pT7DC1–341 (a generous
gift from Dr. Aleem Siddiqui, University of Colorado, Denver, CO) and
cloned into HindIII sites of pcDNA3 vector to generate pcDHCV-341.
The bicistronic reporter vector, pRL HCV 1b, containing two reporter
genes (Renilla luciferase and firefly luciferase) separated by the HCV
IRES was generously provided by Dr. Richard M. Elliot (University of
Glasgow, Glasgow, Scotland, UK). Poliovirus 5-UTR containing bicis-
tronic construct, p2–5, was a generous gift from the laboratory of
Dr. Nahum Sonenberg (McGill University, Montreal, Canada). The
cDNA clone encoding human La autoantigen, pETLa, was obtained
from Dr. Jack Keene (Duke University, Durham, NC). La coding se-
quence was amplified by PCR using the following primers: 5-GACCG-
GATCCATGGCTGAAAATGG-3 and 5-CGTAGAATTCCTACTGGTC-
TCCAG-3. The amplified product was subcloned into BamHI and
EcoRI sites of pRSET-A vector (Invitrogen). The two deletion constructs
pRSET-A La1–208 (La-N) and pRSET-A La209–408 (La-C) were con-
structed using the primers 5-GACCGGATCCATGGCTGAAAATGG-3,
5-GGCCGAATTCTTTAGCTCTTAATT-3, 5-ATATGGATCCCAGGA-
GCAAGAAGC-3, and 5-CGTAGAATTCCTACTGGTCTCCAG-3. The
deletion constructs pRSET-A La1–100 (RRM1) and pRSET-A La101–
208 (RRM2) were also constructed using the primers 5-GACCGGAT-
CCATGGCTGAAAATGG-3, 5-GATCGAATTCACTTCA GGTAGGGG-
3, 5-GGCCGGATCCGAAGTGACTTGGGA-3, and 5-CGTAGAATTC-
CTACTGGTCCCAG-3. Similarly, pRSET-A La209–300 (RRM3) was
amplified by PCR and cloned in pRSET-A vector in BamHI and EcoRI
sites using the following primers: 5-ATATGGATCCCAGGAGCAAGA-
AGC-3 and 5-TCTCGAATTCTCCCAAGTCACCTT-3. All the PCRs
were carried out with 35 cycles, each cycle consisting of denaturation
(95 °C for 40 s), annealing (55 °C for 1 min), and extension (68 °C for 1
min) using Pfx DNA polymerase (Invitrogen).
Purification of La Full-length and Truncated Proteins Using Ni-
NTA-Agarose Column—Escherichia coli BL21 (DE3) cells were trans-
formed with pRSET-A vectors containing either the full-length or the
deletion mutants of La. Single colonies were inoculated into 5 ml of LB
broth containing 75 g/ml ampicillin and grown at 37 °C incubator
shaker at 200 rpm speed until A600 reached 0.6. The cultures were
induced with 0.6 mM isopropyl-1-thio--D-galactopyranoside and grown
for another 4 h. The cells were pelleted and resuspended in 200 l of
lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole). The
extract was made by sonication. The above crude extracts were mixed
with 0.25 volume of Ni-NTA-agarose slurry (Qiagen) and kept for rock-
ing at 4 °C for 2 h. The lysate was loaded onto a column, and the
flow-through was discarded. The column was washed with 5 ml of wash
buffer (50 mM NaH2PO4, 300 mM NaCl, 40 mM imidazole). The bound
protein was eluted with 500 l of elution buffer containing 500 mM
imidazole. The eluted proteins were dialyzed at 4 °C for 4–6 h in 500 ml
of dialysis buffer (50 mM Tris, pH 7.4, 100 mM KCl, 7 mM -mercapto-
ethanol, 20% glycerol), aliquoted, and stored in a 70 °C freezer.
In Vitro Transcription—mRNAs were transcribed in vitro from dif-
ferent linearized plasmid constructs under T7 promoters in run-off
transcription reactions. The HCV bicistronic construct, pRL HCV 1b,
was linearized with HindIII, and poliovirus bicistronic construct, p2–5,
was linearized with XhoI downstream of firefly luciferase to be used as
templates for run-off RNA synthesis. The linear DNA were electro-
phoresed on agarose gels and extracted using silica beads (Bangalore
Genie) and then transcribed using a Ribomax large scale RNA produc-
tion system-T7 (Promega).
Radiolabeled mRNAs were transcribed in vitro using T7 RNA polym-
erase (Promega) and [-32P]uridine triphosphate (PerkinElmer Life
Sciences). The pcDHCV-383 and pcDHCV-341 were linearized with
EcoRI, gel eluted, and transcribed in vitro to generate the 32P-labeled
RNA. The transcription reaction was carried out under standard con-
ditions (Promega protocol) using 2.5 g of linear template DNA at 37 °C
for 1 h 30 min. After alcohol precipitation, the RNA was resuspended in
25 l of nuclease-free water. 1 l of the radiolabeled RNA sample was
spotted onto DE81 filter paper, washed with phosphate buffer, and
dried, and the incorporated radioactivity was measured using liquid
scintillation counter.
Filter-binding Assay—The [-32P]HCV 18–383 RNA or [-32P]HCV
1–341 RNA was incubated with the proteins at 30 °C for 15 min in RNA
binding buffer (containing 5 mM HEPES, pH 7.6, 25 mM KCl, 2 mM
MgCl2, 3.8% glycerol, 2 mM dithiothreitol, and 0.1 mM EDTA), and
loaded onto nitrocellulose filters equilibrated with 2 ml of RNA binding
buffer. The filters were then washed twice with 2 ml of binding buffer
and dried, and the counts retained were measured in liquid scintillation
counter. The graph was plotted with protein concentration (nM) on x
axis and the percentage of bound RNA as the percentage of counts
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retained, on the y axis. The relative affinity constants were calculated
as the protein concentrations at which 50% RNA was bound.
Yeast Transformation—The RNA-hybrid and the protein-hybrid vec-
tors were co-transformed into yeast host strain, L40uraMS2, by lithium
acetate method. The overnight culture grown in 10 ml of YPD medium
(1% yeast extract, 2% peptone, and 2% dextrose) was diluted into 50 ml
of YPD such that A600 is 0.4 and grown for an additional 2–4 h. The cells
were pelleted, washed with 40 ml of 1 TE (10 mM Tris, pH 7.5, 1 mM
EDTA), resuspended in 2 ml of 1 LiAc/0.5 TE buffer (100 mM lithium
acetate, pH 7.5, and 0.5 TE) and incubated at 30 °C for 30 min. 1 g
of each plasmid and 100 g of herring sperm DNA were mixed with 100
l of the yeast suspension and 700 l of 1 LiAc, 40% polyethylene
glycol 3350, 1 TE, and incubated at 30 °C for 30 min. 88 l of Me2SO
was added, and heat shock was given for 15 min at 42 °C. The cells were
washed with 1 TE and plated onto His-selective plates and incubated
at 30 °C. The transformants growing on His plates were later spotted
as different dilutions onto plates containing 10 mM 3-aminotriazole.
Liquid -Galactosidase Assay—The yeast colonies were inoculated
into 5 ml of selective medium and grown overnight. The cells were
harvested and suspended in 100 l of Z buffer (60 mM Na2HPO4, 40 mM
NaH2PO4, 10 mM KCl, 1 mM MgSO4, pH 7.0), 1 mM phenylmethylsul-
fonyl fluoride, and 1% SDS. Cells were disrupted by repeated cycles of
vortexing and cooling in presence of glass beads. 0.8 ml of Z buffer, 1 mM
phenylmethylsulfonyl fluoride, and 1% SDS was added, and 100 l was
set aside for protein estimation. To the remaining, 0.2 ml of 4 mg/ml
ONPG in 200 mM phosphate buffer, pH 7.0, was added and incubated at
room temperature until yellow color developed. The reaction was
stopped by adding 0.5 ml of 1 M Na2CO3, and A420 was measured.
In Vitro Translation—In vitro translation of the capped bicistronic
mRNAs were carried out in micrococcal nuclease-treated rabbit reticu-
locyte lysates (RRL, Promega Corp.). Briefly, 12.5-l reaction mixtures
contained 8.75 l of RRL containing 0.25 l each of minus methionine
and minus leucine amino acid mixtures and 10 units of RNasin (Pro-
mega Corp.). The reaction mixtures were incubated at 30 °C for 1 h and
30 min. 2 l of the reaction mixtures were assayed for both the Renilla
and firefly luciferase activity according to Promega protocol using the
Dual Luciferase reporter assay system. To assay the CAT reporter gene
activity, 2 l of 1:10 dilution of the reactions mixtures were added to 38
l of 0.25 M Tris-HCl, pH 7.4, 2 l of [14C]chloramphenicol in total
volume of 90 l. After incubation at 37 °C for 10 min, 8 l of 10 mM
acetyl-CoA was added and incubated further for 1 h at 37 °C followed by
ethyl acetate (500 l) extraction. The upper organic phase was sepa-
rated and evaporated to dryness. The residues were resuspended in 25
l of ethyl acetate and spotted onto silica gel TLC plates, followed by
chromatography using a mixture of chloroform/methanol (95:5). The
TLC plate was dried and exposed to PhosphorImager, and bands cor-
responding to acetylated and unacetylated forms were quantified. The
relative CAT activity was expressed as a ratio of acetylated form to the
total.
Primer Extension Inhibition Analysis—Primer extension inhibition
(toe-printing) assay was performed as described previously (12). Briefly,
increasing concentration of purified His-tagged La full-length or dele-
tion proteins (200, 400, and 600 ng) were incubated with 2.5 pmol of in
vitro transcribed RNA corresponding to the HCV IRES (18–383), and
binding reaction was performed in a final volume of 20 l at 30 °C for 20
min. To this reaction, 32P-end-labeled primer complimentary to 25
nucleotides of the 3 end of the HCV-383 was added and allowed to
extend using 3 units of avian myeloblastosis virus-reverse transcriptase
(Promega) at 30 °C for 1 h. The cDNAs were alcohol-precipitated, re-
suspended, and compared with the dideoxynucleotide sequence ladders
by electrophoresis on a 6% polyacrylamide, 7 M urea denaturing gel.
Comparative Modeling—Traditional RRMs in the La protein were
searched using the motif search tools such as PROSITE. The known
related crystal and NMR structures of RNA-bound complexes were used
as the basis in modeling the three-dimensional structure of RRM2-RNA
complex. At least six different proteins with complex crystal or NMR
structures of RRMs bound to RNA or DNA are available. The highest
sequence identity between any of the putative RRMs of La proteins and
the RRMs of known structure is on the order of 14%, which is very low.
Such sequence identities are possible even between two entirely unre-
lated proteins of completely different fold. Hence we identified the best
homologues for comparative analysis and modeling on the basis of
highest compatibility of the sequences of putative RRMs in the La
protein with each of the known structures that are bound to RNA. The
structural features considered for compatibility analysis are solvent
accessibility, hydrogen bonding pattern, and secondary structures. It is
important to choose a minimal subset of known structures as the basis
under low sequence similarity situation, as it has been shown earlier
that choosing all the possible structures as basis can result in high
errors in the model (42).
Thus, two constraints were used in choosing the template structures:
(a) the RRM of known structure should be bound to RNA, and (b) the
compatibility of the sequences of RRMs in the La protein with the
chosen structures should be highest. Two different known structures of
RRMs of RNA-bound complexes used in the modeling were: “splicing
factor U2B’’ from human and U1A spliceosomal protein.
The suite of programs encoded in COMPOSER (42) and incorporated
in SYBYL (Tripos Inc., St. Louis, MO) was used to generate the three-
dimensional models of RRMs in La protein. The sequences of the known
structures of RRM proteins were aligned on the basis of their three-
dimensional structures and refined using the structural features such
as solvent accessibility and secondary structures and relationships such
as hydrogen bonding pattern (43, 44). The optimal superposition of C
atoms in the template structures resulted in the identification of the
structurally conserved regions (SCRs) and structurally variable re-
gions. The mean of the topologically equivalent C atoms weighted by
the square of the sequence identity (42) between the RRM in the La
protein and each one of the template structures define the framework
for the family of RRM proteins of known structure. The sequence of an
RRM of La was then aligned with the known structures and the frame-
work. The regions of RRM of the La protein equivalent to the framework
region were modeled from the SCRs of the template structures. To
model a given SCR of RRM-La, the equivalent SCR in a homologue of
known structure with the best local sequence identity with RRM-La is
superimposed on the framework. The variable regions are modeled by
identifying a suitable segment from a known structure in the data bank.
A search is made for a segment having the desired number of residues
and the proper end-to-end distances across the three ‘‘anchor’’ C at the
either side of the putative loop such that the loop can be fitted joining
the contiguous conserved regions. A template matching approach (45) to
rank the candidate loops was also used. The best ranking loop with no
short contacts with the rest of the protein is fitted using the ring-closure
procedure of F. Eisenmenger.2 Side chains are modeled either by ex-
trapolating from the equivalent positions in the basis structure where
appropriate or by using rules derived from the analysis of known
protein structures (46).
Energy Minimization—The COMPOSER-generated model was en-
ergy minimized in SYBYL using the AMBER force-field (47). During the
initial cycles of energy minimization, the backbone was kept rigid and
side chains alone were moved. Subsequently, all atoms in the structure
were allowed to move during minimization. This approach kept disturb-
ance of the backbone structure to the minimum. Energy minimization
was performed until all short contacts and inconsistencies in geometry
were rectified. During the initial stages of minimization, the electro-
static term was not included, as the main objective was to relieve steric
clashes and to rectify bad geometry.
Modeling of the RRM-RNA Complex—The NMR structure of human
U1A protein bound to RNA (48) has been used as the template to model
the binding of RNA in the RRMs of La protein. The choice of 1aud is
made on the basis of the highest sequence similarity of 1aud with RRM2
and RRM3 of La. We have identified the regions of U1A protein that
interacts with RNA and placed the RNA in an identical orientation in
the RRM models of La protein. This has been achieved by optimally
superimposing the RNA-interacting regions of U1A on the equivalent
regions of the RRM model of La and carrying RNA from the U1A protein
complex in the process.
RESULTS
La Protein Interacts with HCV IRES in Vivo in Yeast Three-
hybrid System—Previously, it has been demonstrated that La
autoantigen interacts with the 5-untranslated region of hepa-
titis C virus RNA in vitro and the C terminus effector domain
modulates the binding efficiency (35). In fact several trans-
acting factors have been shown to interact with the HCV 5-
UTR, but so far none of the interactions have been shown in
vivo. To investigate whether La protein interacts with the HCV
IRES RNA in vivo, we took advantage of the genetic screening
method by using yeast three-hybrid system. The system allows
detection of the target RNA (bait) and potential protein (prey)
interaction in a S. cerevisiae strain containing integrated re-
porters (histidine and -galactosidase). Interaction between
2 F. Eisenmenger, unpublished results.
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the bait RNA and the prey protein results in the reconstitution
of transcriptional activation of the reporter genes (His and
LacZ), changing the phenotype of the yeast cells. Positive in-
teractions are detected by selection on His plates and assay-
ing the -galactosidase reporter gene activity. For this purpose,
RNA hybrid vector was generated by cloning the HCV IRES
(18–383 nt) into the pRH5 vector (Invitrogen), which produced
HCV IRES as a fusion to MS2 RNA. The protein hybrid vectors
were generated by cloning the full-length La1–408 as well as
the deletions, La1–208 (La-N) and La209–408 (La-C) into
pYESTrp2 vector, which produces the above proteins as a fu-
sion to B42 activation domain (Fig. 1A). The pYESTrp2 protein
hybrid vectors were co-transformed with the pRH5-HCV RNA
hybrid vector into the host S. cerevisiae (L40uraMS2). The
colonies showing histidine (His)-positive phenotype were se-
lected on His-negative plates. Different dilutions of the trans-
formants were then assayed for the ability to grow on His-
negative plates containing 10 mM 3-amino-1,2,4-triazole (3-AT)
for further screening of specific interaction (Fig. 1B). The trans-
formants were also assayed for -galactosidase activity (-gal),
the relative -galactosidase activities resulting from the inter-
actions are shown in Fig. 1C. The host alone was taken as
background. When pYESTrp2 La1–408 was co-transformed
with pRH5-HCV construct, the growth of the transformants on
His-3-AT plates and almost 6-fold increase in -galactosidase
activity over the background indicated that La protein does
interact with the HCV IRES in the in vivo conditions also. To
confirm that this interaction was because of the bridge formed
by the MS2-HCV hybrid RNA and the B42-La protein, several
controls were used. MS2-HCV with IRP did not show consid-
erable growth at higher dilutions on His-3-AT plates and
there was no significant increase in -gal activity. As expected,
the positive controls, MS2-IRE and the B42-IRP hybrid showed
strong interaction (Fig. 1C). MS2 alone with B42-La did not
show significant -gal activity (data not shown).
Similarly, to investigate whether the La-N or La-C can in-
teract independently with the HCV IRES RNA in vivo, either
the pYESTrp2La1–208 or pYESTrp2La209–408 vector was
co-transformed with the pRH5-HCV RNA hybrid vector. In-
terestingly, both La-N and La-C deletions demonstrated
growth on selective plates (His, 10 mM 3-AT) and modest
increase (4–5-fold) in -galactosidase activity over the negative
controls, indicating significant interaction with the HCV IRES
RNA (Fig. 1). Additionally, we have also investigated the La
protein binding with the HCV-RNA in vitro by UV-cross-link-
ing assays using the full-length and the deletions La1–208
(La-N) and La209–408 (La-C). Results showed that, in addi-
tion to the full-length protein, both the N- and C-terminal
halves of La protein are able to interact with the HCV IRES in
vitro (data not shown).
Both N- and C-terminal Halves of La Protein Are Necessary
to Enhance HCV IRES-mediated Translation—Human La au-
toantigen has been shown to enhance HCV IRES-mediated
translation. Previously, it has been demonstrated that a mu-
tant La protein comprising the C-terminal half (La229–408) is
capable of binding HCV 5-UTR and stimulating the HCV
IRES-mediated translation in RRL, albeit to a lesser extent
compared with the full-length La protein (35). To further char-
acterize the La protein requirement for the HCV IRES func-
tion, the effect of addition of purified N- and C-terminal halves
of La proteins was determined by in vitro translation reactions.
The bicistronic construct containing two reporter genes, Re-
nilla luciferase and firefly luciferase, flanked by the HCV IRES
was used in this experiment. The initiation of cap-independent
translation, occurring internally from HCV 5-UTR, resulted in
the synthesis of firefly luciferase, whereas cap-dependent
translation produced the Renilla luciferase. The capped bicis-
tronic RNA was translated in the presence of increasing con-
centration of either full-length or the truncated La proteins;
the luciferase activities were measured using the Stop and
Glow dual luciferase assay system (Promega) and plotted
against La concentration (Fig. 2A). The results showed gradual
stimulation of luciferase activity up to 4-fold with the in-
crease in concentration (25, 50, and 75 ng; Fig. 2A, lanes 2–4)
of full-length La protein. Furthermore, addition of either the N-
or the C-terminal half of La protein (12.5, 25, and 37.5 ng, Fig.
2A, lanes 5–7 and 8–10) showed modest increase (up to 2.5–3-
fold) in HCV IRES-mediated translation. The result suggests
that the HCV IRES-mediated translation could be stimulated
by specific interaction of independent regions of the La protein.
However, the translation stimulation by either La-N or La-C
was relatively less, compared with the full-length. Thus, we
FIG. 1. Yeast three-hybrid system analysis. A, schematic repre-
sentation of the full-length La protein showing the relative positions of
the three putative RRMs. The protein hybrids and RNA hybrid gener-
ated in pYESTrp2 and pRH5 vectors, respectively, are shown. B, three-
hybrid yeast strain, S. cerevisiae L40uraMS2, was transformed with
plasmids carrying different B42 activation domain fusions and
MS2RNA fusions. The transformants were selected on Trp/Ura/His
medium and subsequently tested for the expression of reporter gene
activity. The positive three-hybrid interactions were further confirmed
by growth on the above medium supplemented with 10 mM 3-aminotria-
zole. C, the relative -galactosidase activity of each transformant is
plotted as vertical bars. The mean and the standard deviations from the
three independent experiments are shown. The cotransformants in
each case are indicated below the bars. IRE-IRP interaction represents
the positive control.
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investigated whether an additive effect on HCV IRES-medi-
ated translation could be achieved by adding both La-N and
La-C together in the same reaction. For this, increasing con-
centrations of La-N and La-C proteins were added together in
equimolar amounts (6.25, 12.5, and 18.75 ng each) in the trans-
lation reactions, and the luciferase activities were measured.
The result showed gradual increase of the HCV IRES-mediated
translation up to 6.5-fold (Fig. 2A, lanes 11–13), which is
equivalent to the level expected with the addition of full-length
La protein. However, no significant increase was observed in
the Renilla luciferase activity (Fig. 2A, shaded bars). The re-
sults suggest that both N- and C-terminal halves might play a
critical role in achieving full stimulatory activity of the full-
length protein.
To further explore the role of N- and C-terminal halves of La
protein in poliovirus IRES-mediated translation, similar exper-
iments were carried out using poliovirus bicistronic construct
(Fig. 2B). Addition of increasing concentrations of full-length
La protein (250, 500 and 750 ng; Fig. 2B, lanes 2–4) gradually
enhanced poliovirus IRES-mediated translation of firefly lucif-
erase up to 2.5-fold. Interestingly, addition of C-terminal half
alone resulted in significant stimulation, up to 2.2-fold (Fig. 2B,
lanes 8–10). However, the N-terminal half lacking the C-ter-
minal effector domain failed to stimulate the poliovirus IRES
activity (Fig. 2B, lanes 5–7). Cap-dependent translations of
CAT gene from the poliovirus bicistronic RNA were not altered
with the addition of either the full-length or the deleted La
proteins (Fig. 2B, shaded bars). Taken together, the results
strongly suggest that, indeed, La protein enhances HCV IRES-
mediated translation, and it appears that deletion of C-termi-
nal effector domain does not abrogate the ability of La protein
to enhance HCV IRES-mediated translation.
Computational Analysis Revealed a Consensus RNA Recog-
nition Pattern in the RRMs of Known Structures—To under-
stand the structural basis of the interaction of La protein with
HCV RNA, we have searched for traditional RRMs (49–52) in
the La protein using the motif search tools. The only region
identified as RRM in the La protein ranges from residue posi-
tion 105 to 200, which is referred to as RRM2. However, be-
cause the overall sequence similarity with proteins of known
structure is low, we confirmed the similarity by comparing
predicted secondary structure of RRM2 with the observed sec-
ondary structures in the RRM-containing proteins of known
structure. Correspondence between observed and predicted
secondary structures is excellent (data not shown), supporting
the view that the region 105–200 could be a RRM domain. We
have assessed the capability of this predicted RRM2 to bind
RNA using three-dimensional structural models. We have used
the known related crystal and NMR structures of RNA bound
complexes as the basis in modeling the three-dimensional
structure of RRM2-RNA complex. We have also analyzed the
other putative RRMs of La protein, RRM1 and RRM3, in a
similar way.
To start with, we analyzed by comparing the known three-
dimensional structural complexes of the RRM-containing pro-
teins. As mentioned under ‘‘Experimental Procedures,’’ not all
the known structures of RRMs are available bound to RNA and
the best sequence similarity between the putative RRMs in La
protein and the known structures is as low as 14%, which is not
significant. We have used the constraints that the structures
useful for modeling and analysis should be bound to RNA and
they should show best compatibility between sequence of RRMs
in La with the observed structural features such as solvent
accessibility and secondary structure. The known structures
that passed these conditions are: spliceosomal U2B-U2A pro-
tein (Ref. 53; code 1a9n), human U1A protein (Ref. 48; code
1aud), hairpin ribozyme inhibitor (Ref. 54; code 1hp6), and U1A
spliceosomal protein (Ref. 55; code 1urn). However, it should be
noted that 1aud, 1hp6, and 1urn practically refer to the same
protein, although the lengths and sequences of bases in the
RNA molecules bound to the known structural complexes vary
substantially. Despite being practically identical sequences,
1aud, 1hp6, and 1urn represent independent complex structure
determination. We had ensured in the comparative modeling
that we take only one of these three structures apart from 1a9n
in generating the framework of the model. Thus, although
these three structures were considered for comparative analy-
sis, we have ensured that our modeling and other results are
not biased.
A detailed investigation of each of these complex structures
revealed that, apart from a short N-terminal region, two loops
are involved in a series of interactions with the RNA. These
interactions are extremely well conserved within the homolo-
gous protein-RNA complex structures whose structure-based
sequence alignment is shown in Fig. 3. Fig. 4A shows the
optimal superposition of the known structures with a consen-
sus stretch of RNA. One of the RNA-interacting loops is cen-
tered around residue position 50 (1aud numbering, Fig. 3),
which links two contiguous -strands, and the other is located
FIG. 2. The effect of exogenous addition of purified full-length
and truncated La proteins on the HCV and poliovirus IRES-
mediated translation. A, 1 g of capped HCV bicistronic RNA was
translated in RRL and supplemented with increasing concentrations of
either purified His-tagged full-length La1–408 (25, 50, and 75 ng) or
La1–208 (12.5, 25, and 37.5 ng) or La209–408 (12.5, 25, and 37.5 ng) or
equimolar amounts of La1–208 and La209–408 proteins together (6.25,
12.5, or 18.75 ng each) as indicated. Both the reporter genes’,
Renilla luciferase and firefly luciferase, activities were measured, and
the relative luciferase units were plotted. The open bars represent the
firefly luciferase activity, and the shaded bars represent the
Renilla luciferase activity. B, a similar experiment was performed with
1 g of capped CAT poliovirus Luc bicistronic RNA supplemented with
full-length La1–408 (250, 500, and 750 ng), La1–208 (125, 250, and 375
ng), or La209–408 (125, 250, and 375 ng) proteins. Open bars represent
firefly luciferase activity, and shaded bars represent the CAT activity.
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around position 85, which links a -strand with the C-terminal
helix. A large majority of the interactions between the protein
and RNA involve the polar atoms in the main chain of the
polypeptide chain. Thus, although the RNA interacting regions
are predominantly located in the loops, these are well con-
served within the RRM proteins of known structure (Fig. 4A). It
is well known that the length and conformation of the “equiv-
alent” loops in homologous proteins vary enormously (42).
However, it can be seen in Fig. 3 that, although the RNA
binding regions are located in the loops, no insertion or deletion
is present in the RNA-interacting loops. Although there are
many residues conserved in the - loop, the sequence at the
- loop is conserved as QYAKTDSD. These conservative fea-
tures are probably the result of the need-based requirement of
RNA binding.
Despite the fact that the bound RNA sequences and sizes
vary enormously, the region of RNA interacting with the two
loops of the protein is a stretch of four bases with a very well
conserved conformation with an overall shape resembling an
‘‘L’’ shape (Fig. 4A). In three of the four structures, the se-
quence of this region of four bases is GCAC, and in 1a9n the
sequence is GCAG. It can be concluded that the known struc-
tures of RRM proteins with RNA bound analyzed here repre-
sent a recognition pattern involving a highly conserved sets of
loops in the protein and a four-base stretch of GCAC/G se-
quence in the RNA. Interestingly, a similar GCAC motif is
observed in the HCV IRES RNA as well.
Structure-based Analysis of RNA Binding Capability of
RRMs in the La Protein—The overall sequence similarity as
seen in Fig. 3 is poor between RRM1 and the known structures
with RRM. This feature could result in overall high structural
variations in RRM1, even in case RRM1 adopts the overall fold
as in the known structures. Significantly, in the - loop
(around position 50 of 1aud), there is an insertion involving a
Phe residue in RRM1. The loop conformation here is markedly
different from the conserved loop conformation seen in the
known structures. Most importantly, in the C-terminal -
region of RRM1, there are three prolyl residues in a stretch of
six residues. Clearly, this stretch is likely to adopt a polyproline
conformation, which is not appropriate in the place of a
-strand as lack of amide group in three places will preclude
proximity of another -strand to form a -sheet structure.
Obviously, a Pro-rich region cannot be accommodated in the
helix as well that follows the -strand in question. If the Pro-
rich region forms a loop linking the -strand and the following
helix, then the polyproline conformation of the loop is very
different from the bent loop conformation seen in the ‘‘equiva-
lent’’ loop of the homologous proteins of known structure. Fur-
ther, the main chain amide is unavailable, in three positions,
for interacting with RNA. Thus, first of all it is not clear
whether RRM1 would form the canonical RRM fold. Even if the
fold of RRM1 is similar to that of known RRM folds, the puta-
tive RNA-interacting regions are likely to adopt conformations
very different from those in the RRM proteins of known struc-
ture. Thus, the RRM1 of La, if it is capable of binding to RNA,
is likely to bind in a novel mode. A three-dimensional struc-
ture-based explanation provided here is consistent with the
proposals of Sobel and Wolin (56) and Ohndorf et al. (57).
From Fig. 3 it can be seen that the sequence of RRM2 of La
protein involves no insertion or deletion at the two critical loop
regions compared with RRM proteins of known structure.
There are a few residue changes in the loop regions compared
with the known structures. However, a detailed investigation
of the model suggests that all the residues in the two loops of
FIG. 3. Structure-based sequence alignment. Sequences of
RRM1, -2, and -3 of La protein were aligned along with the sequences of
known structures of RRM proteins. The structural environments of the
residues in the known structures are encoded in the representation:
uppercase, solvent-inaccessible; lowercase, solvent-accessible; italics,
positive , one of the Ramachandran angles; bold, side-chain hydrogen
bonded to the main-chain amide; underline, side-chain hydrogen
bonded to the main-chain carbonyl. The numbers within parentheses
represent the first residue of the given protein in a block. Conserved
-helical and -strand regions are also indicated. Figure was produced
using JOY (60).
FIG. 4. Computational analysis of RNA recognition motifs. A,
superposition of four known structures of RRM-containing proteins
bound to RNA. The C trace of the proteins are shown in different colors
after the optimal match of the C positions. The consensus GCAC base
sequence regions of the bound RNA in these structures are also shown.
High similarity in the region of RNA bound to the protein can be seen.
B and C, three-dimensional models of RRM2 bound to the RNA with
base sequence GCAC (panel B) and RRM3 (panel C). Helical and
-strand regions are highlighted in different colors. Slightly different
conformations in the region of RNA binding of RRM2 and RRM3 can be
noticed. Panels A–C were produced using SETOR (61).
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RRM2 are comfortably placed in three dimensions. Fig. 4B
shows the modeled structure of RRM2 bound to RNA. Almost
all the residues in the two loops are generally well exposed to
the surroundings in the known structures. The nature of sub-
stitution of residues seen in RRM2 is conservative, involving
good accommodation of the loop sequences in the conformation
seen in the equivalent regions of the known structures. Thus,
the backbone conformations at the two RNA binding loops of
RRM2 are likely to be similar to those seen in the homologous
proteins of known structure. This will result in orientation of
backbone amide and carbonyl groups at the loop regions simi-
lar to that seen in the known structures enabling RNA to bind
at RRM2. Because of the predicted high similarity in the back-
bone structure of RRM2 with the closest homologues, it is
suggested that RRM2 might bind to the GCAC motif in the
HCV IRES RNA.
The overall sequence similarity of RRM3 of La protein with
the RRMs of known structure is significant and is an indication
of the retention of the fold. The sequence of the RRM3 could be
comfortably modeled in the RRM fold (Fig. 4C); however, there
is a deletion of a residue in the - loop, which should alter the
conformation of the loop to some extent. Another putative RNA
binding loop (-) has no deletion or insertion involved, and the
nature of residues are such that the backbone conformation of
this loop in RRM3 is likely to be similar to that of the equiva-
lent region in the homologous structures. Thus, all of the back-
bone region involved in RNA binding is preserved except for a
deletion in the - loop. This may not prevent the RNA binding,
but may accommodate RNA with sequence motifs different
from GCAC.
RRM2 of La Protein Has Greater Affinity for Binding with
the HCV IRES RNA—RRM1 and RRM2 are located at the
N-terminal half, and the RRM3 is located at the beginning of
the C-terminal half of La protein (Fig. 1A). Our computational
modeling data predict that the RRM2 is the most plausible
RRM for the interactions with the HCV IRES. To test this
hypothesis, we have performed filter-binding assay using the
full-length and the La deletion proteins corresponding to each
RRM: La1–100 (RRM1), La101–208 (RRM2), and La209–300
(RRM3). Full-length and truncated La proteins were over-ex-
pressed in E. coli (BL21) and purified by passing through an
Ni-NTA column. 32P-Labeled HCV IRES RNA (18–383 nt)
probe (10 fmol) was separately incubated with increasing con-
centration of each of the deletions. The amount of bound RNA
was determined by binding to nitrocellulose filters and plotted
to obtain the saturation curve (Fig. 5A). The linear portions of
each curve were subjected to regression analysis. The apparent
dissociation constant (Kd) was calculated in each case as the
protein concentration at which 50% of the RNA bound at sat-
uration was retained on the filter. Results showed that La
protein binds to HCV IRES RNA with relatively high affinity,
with an apparent Kd of 0.12 M. As predicted by the computer
modeling data, the filter-binding assay results clearly demon-
strated that RRM2 protein binds to HCV IRES RNA with
relatively high affinity, with an apparent Kd of 0.14 M, closely
similar to that of full-length La protein. However, the protein
corresponding to RRM3 showed relatively lower affinity with
an apparent Kd of 0.23 M. RRM1 protein alone failed to show
significant binding with the HCV IRES RNA, as demonstrated
before in an earlier report.
The computational analysis of the three-dimensional struc-
tures of the RRMs of the La protein predicted that RRM2 might
interact with the HCV IRES around the GCAC motif near the
initiator AUG. To confirm that, we have used HCV IRES mu-
tant (HCV 5-UTR 1–341) lacking the initiator AUG and GCAC
motif as probe RNA in the filter-binding assays. The full-length
La protein and RRM3 showed significant binding with the
mutant HCV IRES with the apparent Kd of 0.24 and 0.37 M,
respectively. However, the RNA binding with RRM2 was dras-
tically reduced possibly because of lack of contact points on the
RNA (Fig. 5, C and D).
Toe-print Analysis Shows the Contact Points of RRM2
around GCAC Motif near Initiator AUG of the HCV IRES
RNA—To precisely map the RRM2 contact points on the HCV
IRES RNA, toe-printing assays were performed. Increasing
concentrations of either purified full-length La protein or dele-
tions were incubated with 5 pmol of in vitro transcribed RNA
corresponding to the HCV IRES (18–383 nt). To this complex,
32P-end-labeled primer complimentary to 24 nucleotides of the
3 end of the HCV-383 was added and extended using avian
myeloblastosis virus-reverse transcriptase. The resulting ex-
tended products were analyzed on a 6% polyacrylamide, 7 M
urea denaturing gel (Fig. 6, panels A and B). For precise map-
ping of the contact points, a DNA sequencing reaction, corre-
sponding to the HCV 383 RNA and using the same end-labeled
primer for priming, was run alongside. The results demon-
strated specific reverse transcriptase pauses (toe-prints) with
the addition of increasing amount of proteins indicating possi-
ble protein binding sites. Four specific toe-prints corresponding
to C-334, A-342, C-355, and A-364 were observed around the
initiator AUG, which showed dose dependence with the addi-
tion of increasing concentrations of full-length La protein (Fig.
6A). RRM2 also showed similar toe-prints; however, prominent
pauses were observed at A-342, C-355, and A-364, whereas, the
contact point C-334 was relatively lesser (Fig. 6B). RRM3 did
not show significant increase in the intensity of the toe-prints
at these points. The results suggest that the primer extension
was inhibited at several points around 342–364 nt, perhaps
FIG. 5. Filter-binding assay to determine the relative binding
affinities of the RRMs. A, [32P]HCV IRES RNA (18–383 nt) was
bound to increasing concentrations of either full-length or truncated La
proteins corresponding to different RRMs (La1–100 (RRM1), La101–
208 (RRM2), and La209–300 (RRM3)) as indicated on the x axis. The
amount of bound RNA was determined by binding to nitrocellulose
filter. The percentage of bound RNA was plotted against the protein
concentration (nM). B, the linear region of the curves in panel A were
plotted and the apparent Kd was calculated as the protein concentration
at which 50% of RNA was retained. C, filter-binding assays were per-
formed as described above using [32P]HCV 5-UTR RNA (1–341) and
increasing concentrations of either full-length and deletion La proteins
(La101–208 (RRM2) and La209–300 (RRM3)) as indicated. The per-
centage of bound RNA was plotted against the protein concentration
(nM). D, the linear regions of the curves in panel C were plotted and the
apparent Kd was calculated as the protein concentration at which 50%
of RNA was retained.
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because of binding of RRM2 with this region encompassing the
AUG (342–344 nt) and the GCAC motif (346–349 nt).
DISCUSSION
La protein interaction with the 5-UTR has been shown to
play a pivotal role in enhancing IRES-mediated translation of
hepatitis C RNA. In this report we have extended the study and
further characterized the interaction in relation to trans-acti-
vation of HCV IRES function. Previously it was shown that the
C-terminal domain of La protein is responsible for binding with
the HCV 5-UTR, largely because of the presence of a stretch of
basic amino acid residues in this region. In contrast, the N-
terminal domain was indicated to play a critical role in inter-
action with poliovirus 5-UTR.
In this report, we demonstrate for the first time the in vivo
interaction of HCV IRES with La protein and also show that
both N- and C-terminal halves are able to interact independ-
ently with the RNA (Fig. 1). HCV IRES-mediated translation
could be stimulated by independent regions of La protein to
some extent but an additive effect was obtained by supplement-
ing La-N and La-C proteins, suggesting that both might play a
critical role in achieving full stimulatory activity (Fig. 2). By
computational analyses we predicted that RRM2 of La protein
might bind HCV IRES at the GCAC motif near initiator AUG
(Figs. 3 and 4), which was confirmed by filter-binding and
toe-printing assays (Figs. 5 and 6).
The binding affinity of full-length La protein for the HCV
IRES (18–383) was found to be significantly high. The major
contributor to the binding is apparently derived from RRM2, as
suggested from the computational modeling data and the filter-
binding assay results. RRM2 showed highest affinity (Kd of
0.14 M) compared with RRM3 (Kd of 0.23 M). RRM1 failed to
show considerable binding affinity for the HCV IRES. This is
consistent with our prediction made based on structural mod-
eling, as well as the earlier observation that the La deletion
1–103 (comprising of RRM1 alone) did not interact with the
HCV 5-UTR. However, the deletion La1–160, where part of
RRM2 was included, showed binding with the HCV 5-UTR
(35).
The region corresponding to amino acids 110–190 of human
La protein represents a canonical RRM designated as RRM2,
which is conserved in diverse organisms. The degree of conser-
vation is consistent with the idea that RRM2 might contribute
to overall affinity of the HCV IRES RNA. This is also supported
by our observations in computational modeling, filter-binding,
and toe-printing assays. Among the three putative RRMs in the
La protein, the sequence pattern in RRM2 is observed to be the
closest to the RRMs of known crystal or NMR structure. Highly
conserved RNA binding regions of known structure coupled
with analysis of RRM-RNA interactions prompts us to predict
that RRM2 of La protein is likely to bind to GCAC motif, which
is located in the HCV IRES. A partially conserved sequence
motif, CACAA, has been observed to be present in several viral
RNAs known to interact with the La protein (35). Our compu-
tational analysis revealed the presence of GCAC motif in all the
known complex structures analyzed that showed structural
homology with RRM2 of human La protein. Interestingly, a
GCAC motif (346–349 nt) was detected immediate downstream
of the initiator AUG and a GCAU sequence (337–340 nt) in the
upstream. Primer extension inhibition assay (toe-printing)
with the HCV IRES and La full-length and RRM2 demon-
strated specific toe-prints at the AUG (342 nt) and few nucle-
otides downstream (355 and 364 nt). Because this region en-
compasses the GCAC (346–349 nt), it is conceivable that the
RRM2 might contact the GCAC motif as predicted by compu-
tational modeling. Additionally, in the filter-binding assay
when HCV IRES probe lacking the GCAC motif and AUG
(1–341 nt) was used, the RRM2 binding was almost abrogated
although it showed highest affinity for binding to HCV IRES
RNA (18–383 nt). The results indicate that perhaps RRM2 does
not bind GCAU in absence of AUG. However, the binding
affinity of RRM3 with HCV IRES was only marginally affected
in absence of GCAC and AUG. Additionally, RRM3 did not
show any specific pause sites at the above region. It is possible
that RRM3 binds to HCV 5-UTR in a location different from
the site that binds RRM2. Consistent with that fact, the full-
length La protein was still able to bind to HCV 1–341 RNA
probe (lacking AUG and GCAC motif) perhaps through RRM3.
The fact that RRM3 binds to a different region other than
RRM2 attests to the possible role of La protein as RNA chap-
erone to hold the RNA-protein complex at the IRES for proper
positioning of the 40 S ribosome onto the initiator AUG.
Although RRM1 does not bind RNA on its own, it contributes
significantly in recognition of UUU-OH-containing RNAs (52).
Additionally, it has been demonstrated earlier that deletion of
the N-terminal residues of RRM1 in mutants 22–408 and 26–
408 decreased the affinity for binding to HIV leader RNA (29).
Analysis of the known structures of RRMs shows highly similar
structures for RRMs bound to RNA and unbound forms. Con-
sistent with this observation, although RRM2 and RRM3 of La
protein may not alter their domain structures significantly as a
result of binding to RNA, it is possible that the relative orien-
tation between the RRM domains of La could alter because of
FIG. 6. Primer extension inhibition (toe-printing) analysis. A,
HCV IRES RNA (18–383 nt) was incubated with increasing amounts
(200, 400, and 600 ng) of La full-length protein (lanes 6–8), as indicated
above the lanes, and analyzed by primer extension. Lane 5 shows the no
protein control. The cDNA products terminated at the sites indicated on
the right. The sequence corresponding to initiator AUG and GCAC is
indicated on the left of the panel. B, similarly HCV IRES RNA (18–383
nt) was incubated in absence of any protein (lane 5) or presence of
increasing concentrations of (200, 400, and 600 ng) of either La100–208
(RRM2) protein (lanes 6–8) or La209–308 (RRM3) protein (lanes 9–11).
The major toe-prints are indicated on the right and the GCAC motif
near AUG is marked on the left of the panel. Lanes 1–4 in each panel
show the DNA sequencing ladder corresponding to the HCV 18–383
RNA obtained by using the same end-labeled primer.
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gross structural changes to suit the orientation of bound RNA.
Thus, RRM1 might influence the access of RNA to RRM2 and
RRM3. Model of the three-dimensional structure of RRM3 re-
veals interesting differences in the RNA binding region. These
changes are predicted not to alter the backbone conformation
essential for RNA binding, but may alter the specificity to the
binding base sequence.
In yeast three-hybrid analysis, longer RNA baits some-
times reduce the reporter gene signal. However, specific in-
teractions have been detected with RNA baits as long as 1600
nt (58). Keeping in mind the multiple contact points of La
protein within HCV 5-UTR, to test the interaction with the
truncated La proteins, we preferred to use a longer RNA
(HCV 18–383) as bait rather than using smaller deletions.
We did observe significant increase in -galactosidase activ-
ity over the control, although the signals were not as high as
expected for optimal length of RNA bait. Additionally, to
avoid signals from nonspecific interaction, we have investi-
gated the growth pattern of the transformed yeast in pres-
ence of 10 mM 3-AT and included various negative controls. In
addition, MS2-HCV (18–383) RNA hybrid did not show any
interaction with another RNA-binding protein, IRP, indicat-
ing high specificity of the assay.
Our in vitro translation results showed dose-dependent stim-
ulation of both HCV and poliovirus IRES-mediated translation
with the addition of increasing concentration of full-length
purified La protein. However, we have deliberately used a
lower range of protein concentrations to monitor the marginal
differences (if any) on the HCV IRES-mediated translation
upon addition of the truncated La proteins. Perhaps because of
this reason, in our assay we could observe stimulation only up
to 4-fold (below saturation level) upon addition of full-length
La protein as opposed to earlier reports, where maximum 6-fold
increase was demonstrated (35). Interestingly, addition of La-N
or La-C protein alone could not stimulate the HCV IRES-
mediated translation to the extent observed with full-length La
protein. However, addition of La-N and La-C together in the
same reaction could achieve 6.5-fold stimulation of HCV
IRES activity, as expected with full-length La protein. This
observation indicates that perhaps both the terminal halves
are involved in some critical protein interactions. Deletion of
either half loses the contribution of some of the factors in
stimulating HCV IRES activity.
The C-terminal half (termed as the effector domain) of La
protein has been shown to possess the dimerization domain,
and La homodimerization is essential for the trans-activation
of poliovirus IRES function (41). The fact that the N-terminal
half alone was capable of stimulating HCV IRES-mediated
translation implies that perhaps La protein dimerization may
not be an essential prerequisite for the HCV-RNA binding
activity and trans-activation of HCV IRES-mediated
translation.
HCV IRES requires a limited number of trans-acting factors
as compared with the picornavirus IRES. The dimerization
domain in the C-terminal half might be involved in protein-
protein interaction with other trans-acting factors that could be
critical for poliovirus IRES-mediated translation but may not
be required for HCV IRES-mediated translation. Alternatively,
a long helix-rich region has been predicted near the center of
the La protein (59), which is almost equally divided into the N-
and C-terminal deletions. The portions of this predicted helix
could also exist in a stable conformation and can mediate
protein-protein interactions. Further experiments are in pro-
gress to distinguish between the possibilities, which would
shed more light on the actual mechanism of the La protein-
mediated stimulation of IRES-mediated translation.
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